Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

553 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of optical coherence tomography-guided PCI in Indian patients with complex lesions: A multicenter, prospective registry.
Chandra P, Sethuraman S, Roy S, Mohanty A, Parikh K, Charantharalyil Gopalan B, Sahoo PK, Kasturi S, Shah VT, Kumar V, Pinto B, Rath PC, Yerramareddy VR, Davidson D, Navasundi GB, Subban V, Livingston N, Rajaraman DP, Narang M, West NEJ, Mullasari A. Chandra P, et al. Among authors: parikh k. Indian Heart J. 2023 Jul-Aug;75(4):236-242. doi: 10.1016/j.ihj.2023.05.008. Epub 2023 May 26. Indian Heart J. 2023. PMID: 37244397 Free PMC article.
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF model.
Burger PM, Savarese G, Tromp J, Adamson C, Jhund PS, Benson L, Hage C, Tay WT, Solomon SD, Packer M, Rossello X, McEvoy JW, De Bacquer D, Timmis A, Vardas P, Graham IM, Di Angelantonio E, Visseren FLJ, McMurray JJV, Lam CSP, Lund LH, Koudstaal S, Dorresteijn JAN, Mosterd A; European Society of Cardiology's Cardiovascular Risk Collaboration (ESC CRC). Burger PM, et al. Eur J Heart Fail. 2023 Nov;25(11):1962-1975. doi: 10.1002/ejhf.3028. Epub 2023 Sep 18. Eur J Heart Fail. 2023. PMID: 37691140 Free article.
One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis-A Multicentre Real-World Experience.
Elkoumy A, Jose J, Terkelsen CJ, Nissen H, Gunasekaran S, Abdelshafy M, Seth A, Elzomor H, Kumar S, Bedogni F, Ielasi A, Arsang-Jang S, Dora SK, Chandra S, Parikh K, Unic D, Baumbach A, Serruys P, Soliman O. Elkoumy A, et al. Among authors: parikh k. J Clin Med. 2023 Mar 20;12(6):2398. doi: 10.3390/jcm12062398. J Clin Med. 2023. PMID: 36983397 Free PMC article.
Unusual outcome of treatment of thymoma with immunotherapy: case report.
Shanshal M, Maakaron J, Parikh K, Moffett JN, Luce AG, Schwecke AJ, Molina J, Leventakos K. Shanshal M, et al. Among authors: parikh k. Mediastinum. 2024 Nov 24;8:54. doi: 10.21037/med-24-20. eCollection 2024. Mediastinum. 2024. PMID: 39781204 Free PMC article.
Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma.
Parikh K, Harris FR, Karagouga G, Schrandt A, Mandrekar J, Johnson S, McCune A, Sadeghian D, Roy D, Polonis K, Gaitatzes A, Bungum AO, Edell ES, Borad MJ, Peikert T, Kosari F, Cheville J, Vasmatzis G, Mansfield AS. Parikh K, et al. JTO Clin Res Rep. 2024 May 18;5(12):100692. doi: 10.1016/j.jtocrr.2024.100692. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39735890 Free PMC article.
Human enteric glia diversity in health and disease: new avenues for the treatment of Hirschsprung disease.
Windster JD, Kakiailatu NJM, Kuil LE, Antanaviciute A, Sacchetti A, MacKenzie KC, Peulen-Zink J, Kan TW, Bindels E, de Pater E, Doukas M, van den Bosch TPP, Yousefi S, Barakat TS, Meeussen C, Sloots CEJ, Wijnen RMH, Parikh K, Boesmans W, Melotte V, Hofstra RMW, Simmons A, Alves MM. Windster JD, et al. Among authors: parikh k. Gastroenterology. 2024 Dec 24:S0016-5085(24)05803-7. doi: 10.1053/j.gastro.2024.12.011. Online ahead of print. Gastroenterology. 2024. PMID: 39725172 Free article.
Author's Response to: Comment on "Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM Database" and "Critical Evaluation of Methodological Approaches in ALK TKI Research: Addressing Confounding Factors and Statistical Robustness".
Parikh K. Parikh K. J Thorac Oncol. 2024 Nov;19(11):e66-e67. doi: 10.1016/j.jtho.2024.08.025. J Thorac Oncol. 2024. PMID: 39510710 No abstract available.
553 results